Dashboard
Manage Tickers

ADNTAdient plc

NYSE adient.com


$ 21.64 $ 0.16 (0.75 %)    

Wednesday, 21-Aug-2024 15:59:46 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 482.88 $ 2.24 (0.47 %)
DIA $ 408.91 $ 0.43 (0.11 %)
SPY $ 560.81 $ 1.92 (0.34 %)
TLT $ 98.72 $ 0.06 (0.06 %)
GLD $ 232.16 $ -0.31 (-0.13 %)
$ 21.63
$ 21.62 x 100
$ 21.64 x 100
-- - --
$ 20.18 - $ 40.47
1,216,600
na
1.92B
$ 2.15
$ 25.90
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-03-2024 03-31-2024 10-Q
3 02-07-2024 12-31-2023 10-Q
4 11-17-2023 09-30-2023 10-K
5 08-02-2023 06-30-2023 10-Q
6 05-03-2023 03-31-2023 10-Q
7 02-07-2023 12-31-2022 10-Q
8 11-22-2022 09-30-2022 10-K
9 08-05-2022 06-30-2022 10-Q
10 05-05-2022 03-31-2022 10-Q
11 02-04-2022 12-31-2021 10-Q
12 11-23-2021 09-30-2021 10-K
13 08-05-2021 06-30-2021 10-Q
14 05-06-2021 03-31-2021 10-Q
15 02-05-2021 12-31-2020 10-Q
16 11-30-2020 09-30-2020 10-K
17 08-06-2020 06-30-2020 10-Q
18 05-05-2020 03-31-2020 10-Q
19 02-07-2020 12-31-2019 10-Q
20 11-22-2019 09-30-2019 10-K
21 08-07-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 02-11-2019 12-31-2018 10-Q
24 11-29-2018 09-30-2018 10-K
25 07-30-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 01-30-2018 12-31-2017 10-Q
28 11-22-2017 09-30-2017 10-K
29 07-31-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-08-2017 12-31-2016 10-Q
32 11-29-2016 09-30-2016 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

what-analysts-are-saying-about-adient-stock
What Analysts Are Saying About Adient Stock
08/14/2024 15:01:34

morgan-stanley-maintains-underweight-on-adient-lowers-price-target-to-21
Morgan Stanley Maintains Underweight on Ad...
08/14/2024 14:54:48

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $32 to $21.

analyst-ratings-for-adient
Analyst Ratings For Adient
08/08/2024 20:03:46

jp-morgan-maintains-neutral-on-adient-lowers-price-target-to-27
JP Morgan Maintains Neutral on Adient, Low...
08/08/2024 16:03:53

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $31 to $27.

barclays-maintains-equal-weight-on-adient-lowers-price-target-to-24
Barclays Maintains Equal-Weight on Adient,...
08/08/2024 12:18:12

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $29 to $24.

ubs-maintains-neutral-on-adient-lowers-price-target-to-24
UBS Maintains Neutral on Adient, Lowers Pr...
08/07/2024 16:00:53

UBS analyst Colin Langan maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $27 to $24.

adient-lowers-fy24-consolidated-sales-outlook-from-prior-148b---149b-to-146b-est-14843b
Adient Lowers FY24 Consolidated Sales Outl...
08/06/2024 10:56:04

adient-q3-2024-sales-3716b-miss-3826b-estimate
Adient Q3 2024 Sales $3.716B Miss $3.826B ...
08/06/2024 10:53:49

Adient (NYSE:ADNT) reported quarterly sales of $3.716 billion which missed the analyst consensus estimate of $3.826 billion by ...

adient-q3-2024-adj-eps-032-misses-064-estimate
Adient Q3 2024 Adj. EPS $0.32 Misses $0.64...
08/06/2024 10:51:48

Adient (NYSE:ADNT) reported quarterly earnings of $0.32 per share which missed the analyst consensus estimate of $0.64 by 50 pe...

b-of-a-securities-maintains-buy-on-adient-lowers-price-target-to-40
B of A Securities Maintains Buy on Adient,...
07/22/2024 17:07:36

B of A Securities analyst John Murphy maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $42 to $40.

jp-morgan-maintains-neutral-on-adient-lowers-price-target-to-31
JP Morgan Maintains Neutral on Adient, Low...
07/22/2024 14:24:38

JP Morgan analyst Ryan Brinkman maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $32 to $31.

how-is-the-market-feeling-about-adient
How Is The Market Feeling About Adient?
07/16/2024 17:45:13

barclays-maintains-equal-weight-on-adient-lowers-price-target-to-29
Barclays Maintains Equal-Weight on Adient,...
07/16/2024 15:47:50

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $34 to $29.

ubs-maintains-neutral-on-adient-lowers-price-target-to-27
UBS Maintains Neutral on Adient, Lowers Pr...
07/10/2024 13:25:51

UBS analyst Colin Langan maintains Adient (NYSE:ADNT) with a Neutral and lowers the price target from $31 to $27.

exane-bnp-paribas-upgrades-adient-to-neutral-announces-26-price-target
Exane BNP Paribas Upgrades Adient to Neutr...
07/01/2024 16:56:22

Exane BNP Paribas analyst James Picariello upgrades Adient (NYSE:ADNT) from Underperform to Neutral and announces $26 price ...

how-is-the-market-feeling-about-adient
How Is The Market Feeling About Adient?
06/27/2024 17:15:18

expert-ratings-for-adient
Expert Ratings For Adient
06/25/2024 14:01:28

wells-fargo-maintains-overweight-on-adient-lowers-price-target-to-32
Wells Fargo Maintains Overweight on Adient...
06/25/2024 13:53:49

Wells Fargo analyst Colin Langan maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $33 to $32.

morgan-stanley-maintains-underweight-on-adient-lowers-price-target-to-32
Morgan Stanley Maintains Underweight on Ad...
05/10/2024 15:30:01

Morgan Stanley analyst Adam Jonas maintains Adient (NYSE:ADNT) with a Underweight and lowers the price target from $35 to $32.

barclays-maintains-equal-weight-on-adient-lowers-price-target-to-34
Barclays Maintains Equal-Weight on Adient,...
05/07/2024 15:23:30

Barclays analyst Dan Levy maintains Adient (NYSE:ADNT) with a Equal-Weight and lowers the price target from $37 to $34.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION